Vincristine Sulfate
Liposomes Injection New Drug Application
Oncology Drug
Advisory Committee meeting:
FDA Briefing Document
Errata Sheet
On
page 4, third paragraph, second sentence, the 3 should be changed to 2.
On
page 4, third paragraph, third sentence, the 3 should be changed to 2.
On
page 7, section 2.3.1.2, the 8th line, 74 should be changed to 73.
On
page 15, in the first Reviewer’s Comment: replace this sentence, “The protocol did not stipulate that
responses had to be confirmed.” with the following “The first version of the protocol did not stipulate that responses
had to be confirmed; however, later versions did.”
On
page 24, third paragraph under Efficacy Analyses, please delete the first
sentence of that paragraph.
On
page 24, third paragraph under Efficacy Analyses, in the fifth sentence change
the 10 to 13.